Drug intelligence / Profile preview

autologous platelet-rich plasma eye drops (Assiut University)

Development stage
Unknown
Lead developer
Assiut University
Administration
Ophthalmic
01

Overview

Autologous platelet-rich plasma (PRP) eye drops are a biologic therapy derived from a patient's own peripheral blood, currently being evaluated by Assiut University for the treatment of persistent corneal epithelial defects and dry eye disease. The preparation involves centrifuging whole blood to obtain a concentrated platelet fraction, which is then diluted for ophthalmic use. PRP contains a high concentration of epitheliotrophic growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), and epidermal growth factor (EGF). These factors promote the proliferation, migration, and differentiation of corneal epithelial cells, facilitating wound healing and the regeneration of the ocular surface in various pathological conditions.

Other names
PRP eye dropsautologous PRP eye dropsplatelet-rich plasma eye drops
02

Targets

PDGFR (PDGFR family)EGFR (Epidermal growth factor receptor)TGFBR (TGF-beta receptor)

Beyond the preview

Go deeper on autologous platelet-rich plasma eye drops (Assiut University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous platelet-rich plasma eye drops (Assiut University).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call